Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
07 oct. 2020 07h58 HE
|
Arch Biopartners
TORONTO, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Ministry...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 10h13 HE
|
ImmunoPhotonics, Inc.
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 04h13 HE
|
ImmunoPhotonics, Inc.
BERN, Switzerland, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers...
Global Systemic Lupus Erythematosus Market – Estimated to Gain Traction with Arrival of Key Pipeline Agents, with Promising Higher Efficacy than Existent Therapies - PMI
20 août 2020 10h35 HE
|
PMI
Covina, CA, Aug. 20, 2020 (GLOBE NEWSWIRE) -- The report "Global Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics),...
RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment
28 mai 2020 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Tusk Therapeutics to be acquired by Roche
28 sept. 2018 01h30 HE
|
Tusk Therapeutics Ltd
Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018: Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...
Rosen Law Firm Reminds Roche Holding AG Investors of Important Deadline in First Filed Class Action – RHHBY
07 juil. 2017 17h15 HE
|
The Rosen Law Firm PA
NEW YORK, July 07, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Roche Holding AG (OTCQX:RHHBY) from March 2, 2017 through June...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Roche Holding AG – RHHBY
23 juin 2017 17h11 HE
|
The Rosen Law Firm PA
NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Roche...
IBRI Drives New Collaboration Model Targeting Type 2 Diabetes
22 déc. 2016 11h45 HE
|
Indiana Biosciences Research Institute
INDIANAPOLIS, Ind., Dec. 22, 2016 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced a new collaboration with Eli Lilly and Company, Roche Diagnostics, the...
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
09 nov. 2015 16h43 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...